BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced a $110 million investment to expand its production of prefillable syringes, helping accelerate ...
Examination of transdermal berberine delivery, GLP-1 pathway terminology in supplement marketing, and consumer evaluation criteria as searches for non-prescription metabolic wellness patches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback